Breakthrough Therapy designation for pain associated with DPN granted by FDA
The period from 2020 to 2022 witnessed a remarkable surge in deal worth
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
The observations are procedural in nature and will be responded to within the stipulated time
The company had earlier announced about the approval received from the MHRA for Liraglutide
Subscribe To Our Newsletter & Stay Updated